https://www.selleckchem.com/pr....oducts/syrosingopine
Although mortality presented no difference between groups, our results suggest that patients benefit from CR with regard to prevention of repeat revascularization. Inflammatory bowel disease poses substantial challenges to travel. We aimed to investigate inflammatory bowel diseases (IBD)-associated challenges to travel, information-seeking behaviour and associated factors. We collected data on patients' demographics, disease characteristics, travel barriers, information-seeking behaviour and travel outcomes in UK, Australi